T, C., HC, G., J, B., MA, B., EG, C., I, C., . . . T, T. (2022). Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial. The Journal of clinical endocrinology and metabolism, 107(8), e3448. https://doi.org/10.1210/clinem/dgac200
Chicago Style (17th ed.) CitationT, Cukierman-Yaffe, et al. "Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial." The Journal of Clinical Endocrinology and Metabolism 107, no. 8 (2022): e3448. https://doi.org/10.1210/clinem/dgac200.
MLA (9th ed.) CitationT, Cukierman-Yaffe, et al. "Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial." The Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 8, 2022, p. e3448, https://doi.org/10.1210/clinem/dgac200.